Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zoetis

148.67
+1.911.30%
Post-market: 148.65-0.0100-0.01%19:16 EDT
Volume:4.24M
Turnover:630.39M
Market Cap:66.32B
PE:27.18
High:150.03
Open:147.23
Low:146.76
Close:146.76
Loading ...

Zoetis Inc: Plans to Immediately Implement Updated Label Based on U.S. Post-Approval Experience With Librela

THOMSON REUTERS
·
04 Feb

Zoetis Announces U.S. Label Update for Librela® (Bedinvetmab Injection), a Treatment to Control Canine Osteoarthritis (Oa) Pain

THOMSON REUTERS
·
04 Feb

Zoetis Announces U.S. Label Update for Librela® (bedinvetmab injection), a Treatment to Control Canine Osteoarthritis (OA) Pain

Business Wire
·
04 Feb

Zoetis Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
01 Feb

Zoetis Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 Jan

Zoetis (ZTS) Stock Moves -0.12%: What You Should Know

Zacks
·
30 Jan

Zoetis Inc. (ZTS): A Bull Case Theory

Insider Monkey
·
30 Jan

Zoetis Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
30 Jan

Morgan Stanley Adjusts Price Target on Zoetis to $243 From $248, Maintains Overweight Rating

MT Newswires Live
·
29 Jan

Zoetis (ZTS) Gets a Buy from Morgan Stanley

TIPRANKS
·
29 Jan

Zoetis Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
29 Jan

Zoetis Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 Jan

Zoetis price target lowered to $205 from $210 at BofA

TIPRANKS
·
28 Jan

Bank of America Securities Reaffirms Their Buy Rating on Zoetis (ZTS)

TIPRANKS
·
27 Jan

Zoetis stands out in weak animal health sector, Piper survey shows

Investing.com
·
25 Jan

Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report?

Zacks
·
23 Jan

SDZNY or ZTS: Which Is the Better Value Stock Right Now?

Zacks
·
23 Jan

Zoetis Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Jan

Zoetis Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
18 Jan

Leerink Partners Adjusts Zoetis Price Target to $205 From $215, Maintains Outperform Rating

MT Newswires Live
·
16 Jan